Navigation Links
BIT Group Restructure Will Consolidate California Facilities to Form BIT USA Inc.
Date:7/22/2013

San Diego, CA (PRWEB) July 22, 2013

BIT Group has announced that this October, the company will unveil a new global executive management restructuring initiative focused on continuous improvement of USA operations while the company continues to grow worldwide. One of the most visible changes will be the consolidation of BIT Group’s two California facilities to form BIT USA Inc. Following a five- year transition of ownership, Source Scientific of Irvine, CA became a wholly-owned BIT Group company in January, 2013. BIT MedTech (formerly California MedTech) was acquired by BIT Group in August, 2011.

The new executive team will be led by BIT Group CEO, Marius Balger, who is currently responsible for BIT Group worldwide; under the new structure, Balger will also serve as CEO of BIT USA. “The USA is an extremely important market for BIT Group,” revealed Balger. “In addition to creating BIT USA Inc. – which will capitalize on economies of scale and offer more customized services to our US customers – we are restructuring our management so as to better focus on our U.S. growth. With a broader presence in the USA, we can offer U.S. customers many BIT Group synergies, such as BIT platform solutions to accelerate products’ time-to-market or a skilled global R&D team to assist with localized projects.”

Other members of the BIT Group executive team include Gotthard von Falkenhausen as Global CFO, and Global COO, Thomas Eck , who, in addition to his executive tasks in Schwalbach, Germany, will oversee BIT Group‘s fast-growing business operations worldwide.

BIT Group provides contract product development, manufacturing and after-sales service for life science research, medical and IVD instrumentation. Quality standards include GMP, FDA registered, ISO13485 & 9001, QSR, Class I, II, and III. BIT global operations in USA, Germany, France, China & Japan deliver precision engineered, cost effective systems solutions. Pre-engineered BIT SMARTSOLUTIONS™ platform technologies reduce development cost and time-to-market; lean manufacturing centers and global supply chain enable competitive product cost.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10949137.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Novel study using new technologies outlines importance of California condor social groups
2. Biotech Investment Group Launches Formex, LLC
3. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
4. World Hematology & Flow Cytometry Market Reviewed in New Venture Planning Group DataPack Available at MarketPublishers.com
5. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
6. KJT Group Hires Director of Health Outcomes
7. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
8. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
9. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
10. Cellular Biomedicine Group Announces Appointment of Corporate Controller
11. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):